C 19 H 13 NO 3 , triclinic, P1 (no. 2), a = 9.4457(6) Å, b = 11.0520 (7) 
Source of material
The title compound was obtained according to the literature method of preparation of 8,9-dimethoxy-2-nitro-*Corresponding author: Zhi Hong, School of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou, 318000, Zhejiang Province, P. R. China, e-mail: zhihong@tzc.edu.cn Yan-Li Zhan, Dang-Ran Yu, Ying Li, Wen-Jia Yuan, and Hong-Yu Zhang: School of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou, 318000, Zhejiang Province, P. R. China 
Experimental details
Hydrogen atoms were placed geometrically and refined using a riding model with d(C-H) = 0.93-0.98 Å, U iso (H) = 1.2 U eq (C) for CH groups. The element of pseudo symmetry in the tiltle structure is a translation along the crystallographic b direction. Generally reflections hkl with k = odd are weaker than those with k = even. All over the structure the translational pseudosymmetry fit is 86% according to the CheckCif program.
Discussion
The 3-nitrochromenes were reported to have pharmaceutically interesting properties, such as anti-breast cancer agents [5] , antifungal activity [6] , flavodoxin inhibitors against helicobacter pylori infection [7] , radioprotective activity [8] and so on. There are two crystallographically independent molecules in the asymmetric unit of the title structure (cf. the figure). They show pseudo-translational symmetry as discussed before [9] . Bond lengths and angels are all in the expected ranges. The dieder angles of O3-C11-C1-C10 is 75°, while the O6-C30-C20-C29 is 110°. The bond angle of C11-C12-C13 is 124.39(13)°, but the C30-C31-C32 is 123.48(13)°.
